Use this URL to cite or link to this record in EThOS:
Title: Effects of cigarette smoke on killer cell activation in chronic obstructive pulmonary disease
Author: Wang, Jia
ISNI:       0000 0004 5358 226X
Awarding Body: University of Nottingham
Current Institution: University of Nottingham
Date of Award: 2015
Availability of Full Text:
Access from EThOS:
Access from Institution:
Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory disease involving both innate and adaptive immune responses. Abnormal numbers of inflammatory cells have been examined in COPD subjects, as well as the effects of cigarette smoking on immune cells and molecules. Killer cells, including CD8+ T cells, NKT-like cells and NK cells, are thought to play a role in the development of COPD through their cytotoxic functions. In this project, we report ex vivo, activation levels of these cell types in COPD patients, as well as effects induced by cigarette smoke extract in vitro. PBMCs were collected from healthy non-smokers (HNS), current healthy smokers (HS), current smokers with COPD (cuS-COPD) and ex-smokers with COPD (exS-COPD). Activation levels of interest and CSE effects on them were analysed by flow cytometry. Killer cells, including CD8+ T cells, NKT-like cells and NK cells, were significantly activated in current smokers with or without COPD compared to healthy non-smokers. Furthermore, KIR (CD158e1) expression was dramatically lower in smokers with or without COPD in comparison with healthy non-smokers. The cytotoxicity of CD8+ T cells from both current smokers and ex-smokers with COPD patients were significantly less than that in healthy volunteers. Also, in vitro, CSE markedly decreased IL-15 treated NK cell activation in current smokers with COPD compared to other three groups. The expression of granzyme B was also significantly inhibited on IL-15 stimulated NK cells when CSE was added. We conclude systemic ex vivo killer cell activation is smoking rather than disease related. Cigrette smoking has immunosuppressive effects on killer cell activation and granzyme B expression in PBMCs from current smokers with COPD.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available
Keywords: RC Internal medicine ; WF Respiratory system